Hepatitis c screening - PowerPoint PPT Presentation


Understanding Newborn Screening in Oklahoma

Newborn screening in Oklahoma is crucial for detecting hidden disorders in newborns that may not be apparent at birth. Early detection through screening can lead to timely treatment, ensuring healthy development and potentially saving lives. The process involves testing every newborn for harmful con

1 views • 88 slides


Epidemiology of hepatitis C in Ireland

Hepatitis C, a viral infection affecting the liver, has notable implications in Ireland, with key transmission routes, clinical manifestations, and long-term consequences shaping its epidemiology. From transmission patterns to chronic infection risks, understanding the natural history and prevalence

0 views • 24 slides



LiveRx Study - Eradicating Hepatitis C in Alberta

LiveRx Study aims to evaluate the impact of a collaborative program involving community pharmacies and organizations in treating HCV in Alberta. By leveraging pharmacist-led interventions, the initiative focuses on increasing HCV screening, diagnosis, and linkage to care, ultimately aiming to eradic

2 views • 13 slides


Patient Screening and Workflow Process Optimization

The flowcharts and descriptions detail the steps involved in identifying eligible patients for screening, managing patient flow during visits, and tracking screening results. The process includes reviewing patient charts, determining screening eligibility, discussing screening options with patients,

2 views • 5 slides


Understanding Lung Cancer Screening Programs and Criteria

Screening for lung cancer is essential for early detection and intervention. CT scans have shown promise in reducing mortality rates, especially in high-risk populations. While challenges like cost and radiation risk exist, initiatives like the National Lung Screening Trial have demonstrated the eff

4 views • 28 slides


Screening for Malnutrition with MUST Tool

Understanding malnutrition is crucial for maintaining optimal health. Screening with the Malnutrition Universal Screening Tool (MUST) is essential to identify individuals at risk. This tool involves assessing BMI, calculating weight loss scores, and determining overall malnutrition risk. Proper scre

5 views • 25 slides


Ensuring Equality of Access to Cervical Screening: Key Considerations

Providing guidance on promoting equality of access to cervical screening, the importance of informed choice, information accompanying screening invitations, and checking for understanding to support individuals making informed decisions. Emphasizes the need for culturally sensitive approaches, espec

5 views • 21 slides


Overview of the NHS Cervical Screening Programme

The NHS Cervical Screening Programme aims to reduce the incidence and mortality of invasive cervical cancer by offering regular screening to eligible individuals. It covers the history, population screening programmes, and key milestones. Learn about the importance, coverage, and guidelines of the p

6 views • 19 slides


Newborn Hearing Screening Program Overview

The Newborn Hearing Screening Project aims to educate healthcare professionals on the importance of early identification of hearing loss in infants. The program discusses the significance of timely intervention, the impact of undetected hearing loss on child development, and provides guidelines for

0 views • 15 slides


Ethiopia's Initial Experience on Hepatitis B Birth Dose Pilot Implementation

Ethiopia's initial experience on Hepatitis B birth dose (HepB-BD) pilot implementation includes background statistics, HBsAg prevalence, hepatitis B vaccination coverage, distribution of HBV infection, existing guidelines/strategies, and activities prior to the start of HepB-BD piloting.

0 views • 17 slides


Clinical Excellence in Hepatitis C Nursing: SCENS Program Overview

Demonstrating competency in infection control, abdominal assessment, specimen collection, and communication is crucial in nursing care for patients with Hepatitis C. The SCENS program focuses on key learning objectives to enhance clinical proficiency, address potential issues, and understand the com

0 views • 12 slides


Understanding Sanction Regime Framework and Screening Controls

The presented content illustrates the sanction regime framework and screening controls, highlighting the significance of sanctions, who should be screened, and what should be included in the screening process. It covers the scope of sanctions, the importance of sanction screening, tools used for scr

3 views • 42 slides


Comprehensive Guide to Screening and Prevention in Family Medicine

This comprehensive guide explores the definitions, uses, and levels of screening and prevention in family medicine. It covers the criteria for screening tests, types of screening, examples of targeted populations, and approaches to preventing common problems in primary care. The content discusses th

0 views • 73 slides


Understanding OSHA Bloodborne Pathogens Training and Hepatitis B Virus

Covering the basics of OSHA Bloodborne Pathogens Standard, this training material provides essential information on bloodborne pathogens, including Hepatitis B Virus (HBV). It emphasizes the importance of training for individuals with occupational exposure, outlining crucial topics such as Hepatitis

2 views • 56 slides


Prostate Cancer Screening Guidelines in Canada: A Snapshot of Strategies

The Canadian Partnership Against Cancer annually collects and summarizes data on national, provincial, and territorial prostate cancer screening guidelines and strategies. Despite the absence of organized screening programs, some provinces have policies in place, with opportunistic screening by prim

0 views • 13 slides


Canine Infectious Hepatitis (ICH) - Overview, Symptoms, and Treatment

Canine Infectious Hepatitis (ICH), also known as Rubarth's Disease, is caused by Canine Adenovirus-1 (CAdV-1), affecting dogs of all ages. The virus primarily targets hepatocytes, leading to acute hepatitis, as well as respiratory and ocular issues. Transmission occurs through contact with infected

6 views • 7 slides


Hepatitis B BD Introduction Plan in Ghana

In Ghana, the introduction plan for Hepatitis B BD involves evaluating disease burden, estimating seroprevalence among pregnant women, obtaining necessary approvals, presenting evidence to NITAG, and seeking support for introduction. A policy for screening and prevention is in place, aiming to addre

1 views • 10 slides


Introduction of Hepatitis B Birth Dose in Mozambique: A Step Towards Comprehensive Prevention

Mozambique is gearing up to introduce the Hepatitis B birth dose as a strategic approach in its immunization program, aiming to tackle the high prevalence of HBV within the population, particularly among women and HIV-positive individuals. The country's existing policies on screening pregnant women

0 views • 15 slides


Best Practices for Racial Equity Rapid Response Outreach

This document outlines suggested practices for a racial equity rapid response outreach program, focusing on a workflow for patient outreach, prioritizing patients based on specific criteria, and components of screening including wellness checks and screening for chronic medical conditions. The workf

0 views • 6 slides


National Viral Hepatitis Control Program - Achieving Universal Health Coverage and Elimination Goals

The National Viral Hepatitis Control Program in India is working towards combating viral hepatitis and achieving SDG goal 3.3 through a comprehensive approach that includes awareness generation, prevention, management, and financing under the NHM. The aim is to eliminate hepatitis C by 2030, reduce

0 views • 19 slides


Importance of Vision Screening for Young Children

Understanding the critical development of vision in young children is crucial, as vision conditions can go undetected but have significant impacts. Early screening helps in identifying refractive errors, amblyopia, and strabismus for successful treatment. Prevalence statistics highlight the importan

0 views • 23 slides


Elimination of Hepatitis C in Individuals With HIV Infection

Discussing the goals, treatment options, and global impact of Hepatitis C in individuals with HIV infection, this presentation by Dr. David L. Thomas from Johns Hopkins Medical Institutions sheds light on important aspects such as mortality projections, WHO elimination goals, and targets for hepatit

0 views • 40 slides


Decline of Hepatitis C in England: 2022 Report Highlights

The 2022 report on Hepatitis C in England shows a continued decline in the prevalence of chronic HCV infection, with around 81,000 individuals estimated to be affected in 2020. The report also highlights the distribution of infections among individuals with different drug injecting histories. Data f

0 views • 41 slides


Implementing Pulse Oximetry Screening for CCHD in Indiana

Indiana implemented pulse oximetry screening for Critical Congenital Heart Disease (CCHD) for all newborns as mandated by state law. The legislation, effective from January 1, 2012, requires every newborn in Indiana to receive CCHD screening, with exceptions only for religious beliefs. The state wor

0 views • 13 slides


Hepatitis C Screening Recommendations for Adults (2017)

The Canadian Task Force on Preventive Health Care (CTFPHC) released recommendations on Hepatitis C screening for adults in 2017. The guidelines provide an overview of screening methods, key findings, implementation considerations, and conclusions. Those at higher risk for HCV in Canada include indiv

0 views • 38 slides


Understanding Zoonotic Hepatitis A Virus Infections

Zoonotic hepatitis A virus infections primarily affect humans and nonhuman primates, with transmission occurring through fecal-oral route. This article delves into the reservoir, mode of transmission, clinical signs, and diagnosis of hepatitis A, shedding light on its impact on both species. Nonhuma

0 views • 22 slides


Epidemiology of Hepatitis B and C in Florida: 2019 Data Analysis

The Department of Health in Florida has released the 2019 data on the epidemiology of Hepatitis B and C as of January 21, 2021. The report includes information on acute and chronic cases, technical notes on case definitions, and changes in national case definitions in 2020. Acute cases require speci

0 views • 35 slides


Understanding Viral Hepatitis: Causes, Types, and Clinical Symptoms

Viral hepatitis is caused by various hepatotropic viruses, including Hepatitis A, B, C, D, and E. This type of liver inflammation can manifest acutely or chronically, leading to symptoms such as jaundice, abdominal pain, nausea, and fatigue. Hepatitis A virus, in particular, is primarily transmitted

0 views • 36 slides


Overview of Hepatitis B Infection in Ireland: Epidemiology, Transmission, and Prevention

Hepatitis B infection is a viral liver disease transmitted through various means such as contact with infected body fluids. The virus can lead to acute or chronic infection, potentially causing severe liver complications. Vaccination programs and lifelong treatment options aim to manage and prevent

0 views • 30 slides


Enhancing Cervical Cancer Screening through NHS Cytology Programme

The NHS Cytology Screening Programme aims to reduce incidence and mortality from cervical cancer by offering systematic, efficient screening for pre-malignant diseases. With a history dating back to 1988, the programme targets women aged 25-64, emphasizing the importance of visualizing the cervix an

1 views • 38 slides


Screening and Prevention in Family Practice

Definition of screening and prevention in family practice along with the Wilson-Jungner criteria, types of screening tests, and examples like colonoscopy and breast cancer screening. Objectives include understanding screening types and targeted populations, pros and cons of screening, and appropriat

0 views • 33 slides


Liver Disease in Canada: An Assessment of the Current Situation

Liver disease in Canada, particularly hepatitis B, is a concerning issue highlighted in the report prepared by the Canadian Liver Foundation in March 2013. The incidence of acute hepatitis B is declining, especially among vaccinated age groups. The prevalence of chronic hepatitis B in Canadian immig

0 views • 58 slides


Guidance for Patients with COVID-19 and Liver Disease Overview

This guidance provides detailed information on COVID-19 and liver disease, covering topics such as COVID-19 overview, liver test abnormalities, co-morbidities, viral hepatitis B and C, metabolic dysfunction, autoimmune hepatitis, clinical care aspects, complications management, screening for HCC, an

0 views • 14 slides


Hepatitis E Surveillance and Notifications in Ireland

The surveillance and notification of Hepatitis E cases in Ireland have been detailed, including the introduction of universal blood donor screening, notifiable disease status, and enhanced surveillance measures. The data shows trends in notifications, blood donor screening results, clinical cases, a

0 views • 13 slides


Understanding Disease Screening and Prevention in Medicine

Explore the concepts of disease screening and prevention in preventive medicine. Learn about the importance of recognizing preclinical cases, the iceberg phenomenon of disease, and the role of medical intervention in arresting disease progression. Discover when to apply screening, the types of scree

0 views • 36 slides


Impact of COVID-19 Response on Hepatitis Elimination in the Americas

The data presented focuses on the impact of the COVID-19 response on hepatitis elimination efforts in the Americas region. It includes information on changes in in-person clinic visits, declines in hepatitis B and C screening and treatment, and disruptions in opioid substitution therapy. The graphs

0 views • 13 slides


Overview of Cervical Cancer Screening Programs in Canada

The Canadian Partnership Against Cancer conducts an annual environmental scan on cervical cancer screening guidelines and strategies across the country. Organized screening programs are available in most provinces, offering services to asymptomatic women at average risk. This scan provides insights

1 views • 46 slides


Advancing Hepatitis C Treatment Financing Model in Cameroon

Exploring a successful financing model to eradicate Hepatitis C in Cameroon through innovative treatments and funding strategies. The initiative aims to identify and treat Hepatitis C carriers in partnership with the Ministry of Health, focusing on expanding treatment access and incorporating a pay-

0 views • 5 slides


Implementation of Flu-FIT Program for Patient Aligned Care Teams at East Orange VA

This study details the adaptation of the Flu-FIT Program to enhance colorectal cancer screening rates within patient aligned care teams at the Veterans Affairs (VA) Department. By linking influenza immunization with colorectal cancer screening using fecal immunochemical testing, the project aimed to

0 views • 10 slides


Impact of COVID-19 on Cancer Screening Rates in Primary Care

This study examines the impact of the COVID-19 pandemic on colorectal, breast, and cervical cancer screening rates in safety-net primary care practices. A 7-year Quality Improvement Project aimed to increase screening rates through tailored education and practice facilitation. The project faced chal

0 views • 5 slides